Non-canonical mutations drive the evolution of persistent Staphylococcus aureus small-colony variants under zinc oxide nanoparticle stress

In the modern world, we rely on tiny particles of metal to keep our wounds clean and our medical devices safe. Among these, zinc oxide nanoparticles are particularly common, acting as powerful, broad-spectrum weapons against bacteria. They work by generating a type of internal stress within the bacterial cell that damages its structure and disrupts its ability to function. For decades, the prevailing belief was that these physical and chemical assaults were so blunt and overwhelming that bacteria could not evolve a way to escape them. Unlike traditional antibiotics, which target specific biological processes that bacteria can eventually mutate to bypass, nanoparticles were thought to be a force of nature that no microbe could outsmart. This assumption has shaped how we use these materials in hospitals and consumer products, operating on the idea that they offer a permanent solution to infection.

However, a new study challenges this certainty by showing that bacteria are far more adaptable than previously imagined. Researchers investigated what happens when Staphylococcus aureus, a common and dangerous bacterium, is exposed to low, non-lethal doses of zinc oxide nanoparticles over a long period. Instead of dying off completely, a small fraction of the bacteria survived and began to change. Over time, these survivors evolved into a distinct, slow-growing form known as a small-colony variant. These new forms were not just tougher; they were fundamentally different in their shape, their metabolism, and even their genetic makeup. The study reveals that prolonged exposure to these nanoparticles does not just kill bacteria; it can select for a persistent, hard-to-kill version that behaves differently than the original strain, raising important questions about the long-term use of nanoparticle-based antimicrobials.

The researchers began by testing how zinc oxide nanoparticles affected a standard strain of Staphylococcus aureus. They found that while the nanoparticles were highly effective at killing the bacteria, they did not wipe out every single cell. Even at high concentrations, a small group of bacteria remained alive. This is a known phenomenon called persistence, where a tiny fraction of a population survives a lethal attack by entering a dormant state, waiting for the threat to pass. To understand how these survivors reacted to the stress, the team looked at the proteins inside the cells. They discovered that the surviving bacteria had completely rewired their internal machinery. They slowed down their metabolism, stopped producing certain energy-generating pathways, and started building thicker cell walls. This shift suggested the bacteria were entering a state of deep dormancy to conserve energy and protect themselves from the oxidative damage caused by the nanoparticles.

As the experiment continued, the researchers observed the emergence of a specific type of survivor: the small-colony variant. These bacteria formed tiny, pale colonies on their growth plates, looking nothing like the large, golden-yellow colonies of the original strain. When viewed under a powerful electron microscope, the differences became even more striking. The small-colony variants were physically larger in diameter but had significantly thicker cell walls than their ancestors. They grew much slower, taking four times as long to double in number. This change in structure and speed was not a temporary reaction; it was a stable, heritable trait. When the researchers kept passing these bacteria through fresh nutrient broth containing the nanoparticles for fourteen generations, the small-colony variants became the dominant form of the population. Even when the nanoparticles were finally removed, the bacteria did not revert to their original form. They had permanently changed.

Perhaps the most surprising discovery came from analyzing the DNA of these evolved bacteria. The researchers expected to find mutations in the genes typically associated with small-colony variants, such as those involved in making heme or menaquinone, which are essential for energy production. Instead, they found a completely different set of genetic changes. The bacteria had acquired mutations in genes that control the cell membrane, the ribosomes (the cell's protein-making machines), and the structure of DNA itself. One specific mutation removed a "stop" signal in a gene, resulting in a longer, more stable protein that likely helped the bacteria manage stress. Furthermore, the bacteria lost a small, circular piece of DNA called a plasmid. This plasmid carried the genes for a classic enzyme that breaks down penicillin.

Here, the story takes a counterintuitive turn. Even though the bacteria lost the genetic tool that usually protects them from penicillin, they became significantly more resistant to it. The amount of penicillin needed to stop their growth increased dramatically. The researchers concluded that this resistance did not come from an enzyme breaking down the drug, but from the physical changes in the bacteria's body. The thickened cell walls and altered membrane structure likely acted as a shield, preventing the antibiotic from reaching its target inside the cell. This suggests that the stress of the nanoparticles forced the bacteria to remodel their entire physical structure, inadvertently making them harder to kill with certain traditional antibiotics.

The study also examined how these new, tough bacteria interacted with human cells. The evolved variants were much better at sticking to lung cells and surviving inside immune cells called macrophages. In tests, they persisted inside these immune cells for much longer than the original bacteria, suggesting they are better equipped to hide from the body's natural defenses. This ability to hide and survive inside the host is a hallmark of chronic, recurring infections that are notoriously difficult to treat. The findings indicate that the evolutionary path taken by these bacteria was not a simple case of becoming resistant to everything. They did not become immune to the nanoparticles themselves; the nanoparticles still killed about two-thirds of them, whereas they killed almost all of the original strain. Instead, the bacteria traded speed and size for durability and stealth.

This research highlights a complex evolutionary trade-off. By surviving the stress of the nanoparticles, the bacteria developed a suite of traits—slow growth, thick walls, and altered genetics—that made them persistent and harder to treat with some common drugs. While they did not become invincible, they transformed into a form that is much more difficult to eradicate. The study serves as a reminder that the widespread use of antimicrobial materials, even those thought to be physically unassailable, can apply a selective pressure that shapes bacterial evolution in unexpected ways. It suggests that in the long run, the continuous use of these materials might inadvertently encourage the rise of bacterial populations that are better at hiding, surviving, and resisting treatment, turning a short-term solution into a long-term challenge for public health.